Moreover, Ntn4 level was dramatically up-regulated in both tumor tissues and serum samples of GC patients, and the high expression of Ntn4 was significantly correlated with a short survival time and a high TNM stage, indicating it may be used as a potential non-invasive biomarker for diagnosis and prognosis of GC. This evidence concerns the gene NTN4 and neoplasm.